LAP3 and neoplasm: HepG2 cells, with a higher concentration of endogenous LAP have greater resistance than A549 cells, which indicates that the tumor cells with a higher concentration of intracellular LAP may obtain more significant intrinsic resistance toward cisplatin via the alteration of the intracellular interactive pathways (Figure 27C).